Detlef Albrecht - Jun 3, 2022 Form 4 Insider Report for Satsuma Pharmaceuticals, Inc. (STSA)

Role: Chief Medical Officer
Signature: /s/ Thomas P. O'Neil as Attorney in Fact for Detlef Albrecht, M.D.
Stock symbol: STSA
Transactions as of: Jun 3, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/7/2022, 05:39 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STSA	Stock Option (Right to Buy)	Award	$0	+190K		$0.00	190K	Jun 3, 2022	Common Stock	190K	$3.46	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Twenty Five Percent (25%) of the shares subject to the option vest one year measured from June 3, 2022 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.